| Value | ₹1,580 Cr |
|---|
BSE filing, NSE: DEVYANI. Summary written from the filing by ALFA Finder's alert engine.
Devyani International Ltd: key numbers
- Share price
- ₹120.40
- Market cap
- ₹14,845 Cr
- Revenue (annual)
- ₹5,611 Cr
- Net profit (annual)
- ₹-38.63 Cr
- P/E (TTM)
- -536.5×Sector 43.7×
- Promoter holding
- 61.36%+0.00% QoQ
- FII holding
- 6.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Devyani International Ltd
All →Devyani International Earnings Call Transcript: Key Takeaways
Management maintains expansion optimism despite inflation and seasonality pressures affecting brand margins.
Devyani International Results Update
Devyani International reported Q2 FY27 revenue of INR 1,519 Cr (up 10.4% YoY) and EBITDA of INR 229 Cr. Store network reached 2,325 with 70 net additions; CCI merger approval also noted.
- QSR store network
- 2325 stores
Devyani International Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 1,519 Cr (+10.4% YoY), EBITDA INR 229 Cr (+18%), PAT INR 3.5 Cr vs prior loss. Growth led by SSSG recovery and cost control.
Devyani International Q2 FY27 Results: Turns Profitable, Net Profit ₹3.5 Cr
Devyani International Ltd reported revenue from operations of ₹1,519 Cr (+10.4% YoY) and net profit of ₹3.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹3.5 Cr
Devyani International Acquisition
Devyani International got CCI approval for its proposed merger with Sapphire Foods India. The detailed CCI order is awaited; no monetary value is disclosed.
Devyani International Board Meeting Date
Devyani International will hold a board meeting on November 2, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until November 4, 2026.
Other results update announcements
All →Wonderla Holidays Results Update
Wonderla reports best-ever Q2 with 42% income growth to ₹126 Cr and 90% EBITDA growth. H1 income up 41% to ₹378 Cr driven by new Chennai park.
UPL Results Update
UPL's Q2 FY27 revenue was ₹11,860 Cr with EBITDA of ₹2,312 Cr. H1 operational PATMI rose 33% YoY on sustained margin expansion.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
JTL Defence Results Update
JTL Defence reported H1 FY27 revenue of Rs.410 Cr, up 11.4x YoY, with EBITDA of Rs.47 Cr. Adjusted PAT of Rs.3 Cr was impacted by asset revaluation depreciation.
Mold-Tek Packaging Results Update
Mold-Tek reported Q2 FY27 net profit up 36% to Rs 21.06 Cr and H1 profit up 23% to Rs 46.67 Cr. Revenue and sales volumes also rose across both periods.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.